Catalyst
Slingshot members are tracking this event:
Novartis (NVS) CANTOS to share Phase 3 data on ACZ-885 targeting inflammation to reduce cardiovascular risk on August 27th. 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| NVS | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 27, 2017
Occurred Source:
https://www.novartis.com/news/media-releases/novartis-announces-analysis-published-lancet-showing-acz885-reduced-lung-cancer
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Cantos, Phase 3 Data, Acz-885, Cardiovascular Risk
